Methamphetamine hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for methamphetamine hydrochloride and what is the scope of patent protection?
Methamphetamine hydrochloride
is the generic ingredient in three branded drugs marketed by Ajenat Pharms, Teva, Able, Dr Reddys Labs Sa, Hikma, and Rexar, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.There are four drug master file entries for methamphetamine hydrochloride. Two suppliers are listed for this compound.
Summary for methamphetamine hydrochloride
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 6 |
NDAs: | 7 |
Drug Master File Entries: | 4 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 31 |
Clinical Trials: | 141 |
Patent Applications: | 2,779 |
What excipients (inactive ingredients) are in methamphetamine hydrochloride? | methamphetamine hydrochloride excipients list |
DailyMed Link: | methamphetamine hydrochloride at DailyMed |
Recent Clinical Trials for methamphetamine hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Florida | Early Phase 1 |
Carolyn Rodriguez | Phase 2 |
Canadian Institutes of Health Research (CIHR) | Phase 2 |
Pharmacology for methamphetamine hydrochloride
Drug Class | Amphetamine Anorectic Central Nervous System Stimulant |
Physiological Effect | Appetite Suppression Central Nervous System Stimulation Increased Sympathetic Activity |
Medical Subject Heading (MeSH) Categories for methamphetamine hydrochloride
US Patents and Regulatory Information for methamphetamine hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dr Reddys Labs Sa | METHAMPHETAMINE HYDROCHLORIDE | methamphetamine hydrochloride | TABLET;ORAL | 091189-001 | Apr 21, 2010 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Ajenat Pharms | DESOXYN | methamphetamine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 005378-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Teva | METHAMPHETAMINE HYDROCHLORIDE | methamphetamine hydrochloride | TABLET;ORAL | 086359-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Teva | METHAMPEX | methamphetamine hydrochloride | TABLET;ORAL | 083889-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Ajenat Pharms | DESOXYN | methamphetamine hydrochloride | TABLET;ORAL | 005378-002 | Approved Prior to Jan 1, 1982 | AA | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Rexar | METHAMPHETAMINE HYDROCHLORIDE | methamphetamine hydrochloride | TABLET;ORAL | 084931-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.